Opinion: Exorcising Ghostwriting from Peer Review

Training young scientists to review submitted manuscripts should be an academic exercise, not a facet of professional scientific publishing.

Written byJames L. Sherley
| 4 min read
a hand using a red pencil to mark up a draft

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

ABOVE: © ISTOCK.COM, ANDREYPOPOV

On November 4, 2019, The Scientist ran a revealing Q&A highlighting a recent survey published in eLife. Responses from early career researchers (ECRs) and other scientists drew attention to a widespread, unethical practice to which academic scientists have too long resigned themselves—peer review ghostwriting (8:e48425, 2019).

As defined in that paper, peer review ghostwriting occurs when scientists hand over manuscripts that they have agreed to review for journal editors to graduate students or postdocs in their research groups. The involvement of the junior scientists is not typically disclosed to the journal, so editors work under the impression that the invited reviewer developed and wrote the resulting manuscript review themselves.

Survey results reported in the eLife paper provided the first quantitative evidence for the prevalence of this practice, as well as for the practice the study authors refer to as co-reviewing. In a strict sense, co-reviewing happens ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

January/February 2020

A Light in the Dark

Unpacking the Complex Neurobiology of Suicide

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies